John Kwon

Array ( [id] => 9575328 [patent_doc_number] => 08765742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Crystalline methylthioninium chloride hydrates' [patent_app_type] => utility [patent_app_number] => 13/497686 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8937 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446480 [patent_doc_number] => 08288533 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-10-16 [patent_title] => 'Methods for preparing benzoxazines using aqueous solvent' [patent_app_type] => utility [patent_app_number] => 12/888850 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3952 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12888850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10515908 [patent_doc_number] => 09242946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-26 [patent_title] => 'High purity diaminophenothiazinium compounds including methylthioninium chloride (MTC)' [patent_app_type] => utility [patent_app_number] => 12/875465 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34264 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12875465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617622 [patent_doc_number] => 20100324033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 12/872580 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47144 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324033.pdf [firstpage_image] =>[orig_patent_app_number] => 12872580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371161 [patent_doc_number] => 20120220552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => '(THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/393497 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 46665 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401921 [patent_doc_number] => 20100305110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'CONDENSED IMIDAZOLE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/857032 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8799 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305110.pdf [firstpage_image] =>[orig_patent_app_number] => 12857032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993888 [patent_doc_number] => 20110015392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'PROCESS FOR PREPARING PYRIDONE DERIVATIVES 226' [patent_app_type] => utility [patent_app_number] => 12/854388 [patent_app_country] => US [patent_app_date] => 2010-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12180 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015392.pdf [firstpage_image] =>[orig_patent_app_number] => 12854388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6098481 [patent_doc_number] => 20110003985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'CYCLOPENTAPHENANTHRENE-BASED COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/850010 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10541 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003985.pdf [firstpage_image] =>[orig_patent_app_number] => 12850010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555481 [patent_doc_number] => 08329953 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Cyclopentaphenanthrene-based compound and organic electroluminescent device using the same' [patent_app_type] => utility [patent_app_number] => 12/849949 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10622 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12849949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8410370 [patent_doc_number] => 08273767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Bicyclic-substituted amines as histamine-3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 12/849697 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78853 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12849697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929878 [patent_doc_number] => 20110039837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 12/849225 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47145 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039837.pdf [firstpage_image] =>[orig_patent_app_number] => 12849225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9711057 [patent_doc_number] => 08835628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Stable and highly tunable metathesis catalysts' [patent_app_type] => utility [patent_app_number] => 13/813397 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 20516 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196708 [patent_doc_number] => 20110028466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'NITROIMIDAZOOXAZINE AND NITROIMIDAZOOXAZOLE ANALOGUES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/847459 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 51188 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028466.pdf [firstpage_image] =>[orig_patent_app_number] => 12847459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6025983 [patent_doc_number] => 20110053909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Compounds - 801' [patent_app_type] => utility [patent_app_number] => 12/847000 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 83373 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053909.pdf [firstpage_image] =>[orig_patent_app_number] => 12847000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136769 [patent_doc_number] => 20110009418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN' [patent_app_type] => utility [patent_app_number] => 12/846689 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58219 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009418.pdf [firstpage_image] =>[orig_patent_app_number] => 12846689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6618207 [patent_doc_number] => 20100324064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'NOVEL ANALOGS OF CHOLINE FOR NEUROPROTECTION AND COGNITIVE ENHANCEMENT IN NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/841684 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10236 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324064.pdf [firstpage_image] =>[orig_patent_app_number] => 12841684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710900 [patent_doc_number] => 08835469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Substituted benzamide derivatives as glucokinase (GK) activators' [patent_app_type] => utility [patent_app_number] => 13/387885 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27602 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388508 [patent_doc_number] => 20100317670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN' [patent_app_type] => utility [patent_app_number] => 12/840936 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53640 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317670.pdf [firstpage_image] =>[orig_patent_app_number] => 12840936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336101 [patent_doc_number] => 20120202804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'FUSED AMINODIHYDRO-OXAZINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/386092 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40078 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8625203 [patent_doc_number] => 08357698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-22 [patent_title] => 'Diacyl indazole derivatives as lipase and phospholipase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/839863 [patent_app_country] => US [patent_app_date] => 2010-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14464 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12839863 [rel_patent_id] =>[rel_patent_doc_number] =>)